Guang Fu

473 total citations
16 papers, 309 citations indexed

About

Guang Fu is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Guang Fu has authored 16 papers receiving a total of 309 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Surgery. Recurrent topics in Guang Fu's work include Cancer Research and Treatments (2 papers), Eicosanoids and Hypertension Pharmacology (2 papers) and Inflammasome and immune disorders (2 papers). Guang Fu is often cited by papers focused on Cancer Research and Treatments (2 papers), Eicosanoids and Hypertension Pharmacology (2 papers) and Inflammasome and immune disorders (2 papers). Guang Fu collaborates with scholars based in China and United States. Guang Fu's co-authors include Timothy R. Billiar, Patricia Loughran, Melanie J. Scott, Meihong Deng, Ping Sun, Chenxuan Yang, Lei Zhao, Zhongjie Yi, Wenbo Li and Shilai Li and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Hepatology.

In The Last Decade

Guang Fu

11 papers receiving 309 citations

Peers

Guang Fu
Comparison fields: 5 of 62
  • Molecular Biology 154
  • Immunology 132
  • Epidemiology 80
  • Surgery 36
  • Hepatology 30
Replace Yizhu Tian with:
Yizhu Tian China
Dayan Cao China
Chenxuan Yang China
Palma Aurelia Iacovazzi Italy
Jufang Yao China
Rui Yan China
Bráulio Henrique Freire Lima Brazil
Theresa H. Wirtz Germany
Wenjun Du China
Maili Zimmermann Netherlands
Yizhu Tian China View profile →
Citations per field, relative to Guang Fu
Guang Fu · 1×
Citations per year, relative to Guang Fu
Guang Fu · 1×

Countries citing papers authored by Guang Fu

Since Specialization
Citations

This map shows the geographic impact of Guang Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guang Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guang Fu more than expected).

Fields of papers citing papers by Guang Fu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guang Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guang Fu. The network helps show where Guang Fu may publish in the future.

Co-authorship network of co-authors of Guang Fu

This figure shows the co-authorship network connecting the top 25 collaborators of Guang Fu. A scholar is included among the top collaborators of Guang Fu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guang Fu. Guang Fu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
# Work Indexed citations
1 0
2 0
3 1
4 0
5 2
6 1
7 28
8 0
9 28
10 35
11 147
12 3
13 62
14 1
15
[Inhibitory effect against the gastric carcinoma cell growth by the combination of the survivin antisense oligonucleotide and P53 gene].
0
16 1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026